Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients.
about
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease.Immune profile of pediatric renal transplant recipients following alemtuzumab induction.Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment responseNovel therapies in transplantation.The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.Current status of immunosuppressive agents for solid organ transplantation in children.Pediatric kidney transplantation: a historical review.Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation.Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.CD52 ligation induces CD4 and CD8 down modulation in vivo and in vitro.
P2860
Q34488656-A004F3B7-D17A-40E5-BB9B-45FCF441221EQ35634116-F0D02ACF-D864-49E0-961A-D7A7DFCA2E3DQ35720801-CBA623CB-B498-43CE-B32C-1429F261C999Q36024673-113158D9-44A1-47C5-B86C-D5345A458689Q36099424-80EFB40C-7F33-4A38-9447-CE7598B03525Q36570565-6A3BD250-90D9-477A-9756-E7667EC80185Q37810958-5BD66DA7-F105-4471-BAA1-C228A56EA5E0Q37987565-52787DE8-9BE1-405A-A2F9-A7B2B5011D4FQ38812385-059068AC-D917-4CDE-86B6-D763C5511A62Q39409394-7CC456A0-F798-44FF-AE5F-B44B23F6940FQ41810263-30F97462-8C0E-4434-BD21-0AF38889A4ADQ41897278-3A13A819-0D0F-4177-8F88-4F87F4375653Q42226145-9292676C-A7AF-402C-B961-C621948EDDE6Q53604503-2532CA3E-FBF4-47EA-A7CA-116BB8AB38F0
P2860
Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Present experience with Campat ...... l use in pediatric recipients.
@ast
Present experience with Campat ...... l use in pediatric recipients.
@en
type
label
Present experience with Campat ...... l use in pediatric recipients.
@ast
Present experience with Campat ...... l use in pediatric recipients.
@en
prefLabel
Present experience with Campat ...... l use in pediatric recipients.
@ast
Present experience with Campat ...... l use in pediatric recipients.
@en
P1476
Present experience with Campat ...... l use in pediatric recipients.
@en
P2093
Stuart J Knechtle
P304
P356
10.1046/J.1399-3046.2003.00139.X
P577
2004-04-01T00:00:00Z